# T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform
Canonical URL: https://biopharmsignal.com/news/TTOO/t2-biosystems-inc-and-prxcision-inc-announce-co-marketing-collaboration-for-rapid-direct-from-blood-diagnostics-and-ai-powered-decision-support-platform
Ticker: TTOO
Company: T2 Biosystems
Source: T2 Biosystems
Published: 2024-10-08 13:00 EST
Original Source URL: https://investors.t2biosystems.com
## Summary

Pioneering a new frontier in antibiotic stewardship to combat the growing threat of antimicrobial resistance LEXINGTON, Mass. and SCHENECTADY, N.Y. , Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic

## Article Body
Pioneering a new frontier in antibiotic stewardship to combat the growing threat of antimicrobial resistance LEXINGTON, Mass. and SCHENECTADY, N.Y. , Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic
## Recent Company News
- 2025-01-07 14:00 EST — [T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results](https://biopharmsignal.com/news/TTOO/t2-biosystems-announces-preliminary-fourth-quarter-and-full-year-2024-financial-results) — Source: T2 Biosystems
- 2024-12-18 14:00 EST — [T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor](https://biopharmsignal.com/news/TTOO/t2-biosystems-announces-sale-of-four-t2dx-instruments-to-existing-european-distributor) — Source: T2 Biosystems
- 2024-12-17 14:00 EST — [T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally](https://biopharmsignal.com/news/TTOO/t2-biosystems-achieves-key-milestone-with-250-000th-novel-sepsis-test-shipped-globally) — Source: T2 Biosystems
- 2024-12-16 14:00 EST — [T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.](https://biopharmsignal.com/news/TTOO/t2-biosystems-announces-extension-of-multi-year-capital-equipment-supplier-agreement-with-vizient-inc) — Source: T2 Biosystems
- 2024-12-09 14:00 EST — [T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens](https://biopharmsignal.com/news/TTOO/t2-biosystems-announces-plans-to-license-its-proprietary-technology-to-expand-its-leadership-in-direct-from-whole-blood-detection-of-sepsis-causing-pathogens) — Source: T2 Biosystems
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)